Source - RNS
RNS Number : 3880X
Spire Healthcare Group PLC
09 August 2018
 

9 August 2018

 

Spire Healthcare Group plc (the "Company" or "Spire")

 

 

Acquisition of Spire Healthcare shares by Spire Directors

 

The following Spire Directors each purchased shares in the Company today as detailed:

 

Director

Position

Shares purchased

Price

Holding post announcement

Justin Ash

Chief Executive Officer

125,000

159.99 pence

345,100

Peter Bamford

Deputy Chairman and Senior Independent Director

10,000

160.92 pence

19,000

Garry Watts

Chairman

100,000

159.996 pence

603,577

 

 

Enquiries:

Philip Davies

Deputy Company Secretary

020 7427 9092

 

The following disclosure is made in accordance with Article 19 of the EU Market Abuse Regulation 596/2014.

 

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

 

Justin Ash

2

Reason for the notification

a)

Position/status

 

Chief Executive Officer

b)

Initial notification /Amendment

 

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

 

Spire Healthcare Group plc

b)

LEI

213800IBJPW3SE2RA350

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary shares of 1 pence each

b)

Nature of the transaction

Purchase of 125,000 ordinary shares at 159.99 pence each

c)

Price(s) and volume(s)

Price(s)

Volume(s)

159.99 pence

125,000


d)

Aggregated information

- Aggregated volume

- Price

As above

e)

Date of the transaction

2018-08-09

f)

Place of the transaction

XLON

 

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

 

Peter Bamford

2

Reason for the notification

a)

Position/status

 

Deputy Chairman and Senior Independent Director

b)

Initial notification /Amendment

 

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

 

Spire Healthcare Group plc

b)

LEI

213800IBJPW3SE2RA350

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary shares of 1 pence each

b)

Nature of the transaction

Purchase of 10,000 ordinary shares at 160.92 pence each

c)

Price(s) and volume(s)

Price(s)

Volume(s)

160.92 pence

10,000


d)

Aggregated information

- Aggregated volume

- Price

As above

e)

Date of the transaction

2018-08-09

f)

Place of the transaction

XLON

 

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

 

Garry Watts

2

Reason for the notification

a)

Position/status

 

Chairman

b)

Initial notification /Amendment

 

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

 

Spire Healthcare Group plc

b)

LEI

213800IBJPW3SE2RA350

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary shares of 1 pence each

b)

Nature of the transaction

Purchase of 100,000 ordinary shares at 159.996 pence each

c)

Price(s) and volume(s)

Price(s)

Volume(s)

159.996 pence

100,000


d)

Aggregated information

- Aggregated volume

- Price

As above

e)

Date of the transaction

2018-08-09

f)

Place of the transaction

XLON

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
DSHBSGDIUXGBGIC

Related Charts

Spire Healthcare Group (SPI)

+38.05p (+22.89%)
delayed 05:00AM